The inhibition of metalloproteinases to treat osteoarthritis: reality and new perspectives
- 1 January 2002
- journal article
- Published by Taylor & Francis in Expert Opinion on Therapeutic Patents
- Vol. 12 (1) , 29-43
- https://doi.org/10.1517/13543776.12.1.29
Abstract
No abstract availableKeywords
This publication has 78 references indexed in Scilit:
- Expression of ADAMTS Homologues in Articular CartilageBiochemical and Biophysical Research Communications, 1999
- Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage.Journal of Clinical Investigation, 1997
- Expression of Members of a Novel Membrane Linked Metalloproteinase Family (ADAM) in Human Articular ChondrocytesBiochemical and Biophysical Research Communications, 1997
- Degradation of type II collagen, but not proteoglycan, correlates with matrix metalloproteinase activity in cartilage explant culturesArthritis & Rheumatism, 1997
- The new collagenase, collagenase-3, is expressed and synthesized by human chondrocytes but not by synoviocytes. A role in osteoarthritis.Journal of Clinical Investigation, 1996
- Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage.Journal of Clinical Investigation, 1996
- Recombinant human inteleukin-1 inhibits plasminogen activator inhibitor-1 (PAI-1) production by human articular cartilage and chondrocytesBiochemical and Biophysical Research Communications, 1991
- Cathepsin B and cysteine protease inhibitors in human osteoarthritisJournal of Orthopaedic Research, 1990
- Evidence for metalloproteinase and metalloproteinase inhibitor imbalance in human osteoarthritic cartilage.Journal of Clinical Investigation, 1989
- Endogenous Activation of Latent Collagenase by Rheumatoid Synovial CellsNew England Journal of Medicine, 1977